Study Stopped
Covid restrictions prevented continuation during the funding window
Modulating Default Mode Network Function: A Transcranial Direct Current Stimulation (TDCS) Pilot Study
MDMN
1 other identifier
interventional
4
1 country
1
Brief Summary
The primary purpose of this research is to gather scientific information about how different people's brains work when they look at different types of pictures. This will help to improve the investigators' understanding of the way the brain works for people who are depressed or anxious, and this knowledge could help lead to better diagnosis and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2020
CompletedFirst Submitted
Initial submission to the registry
October 10, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedResults Posted
Study results publicly available
January 4, 2022
CompletedJanuary 4, 2022
December 1, 2021
1.4 years
October 10, 2020
August 30, 2021
December 5, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Blood Oxygen Level Dependent (BOLD) Response in the Precuneus During an Emotion Regulation Task Completed During fMRI Scanning.
The investigators will determine the effects of TDCS on BOLD response in the precuneus/posterior cingulate gyrus. The BOLD signal is a measure of regional blood flow in the brain and is used as a proxy for neural activity in specific brain regions. Values below represent pre-post change in BOLD response to the emotion regulation task that participants complete during fMRI scanning. We hypothesize that tDCS applied to the target used in this study will decrease BOLD signal (lower values) during critical components of this task, normalizing function in this region.
1 week (between baseline and repeat scanning)
Secondary Outcomes (1)
The Percentage of Patients Who Reported a Side Effect in the Active tDCS Condition But Not the Sham tDCS Condition
30 minutes to 1 hour (the period during which the tDCS device was worn) on each of two scan days
Study Arms (1)
Transcranial Direct Current Stimulation during fMRI
EXPERIMENTALEach subject will undergo transcranial direct current stimulation twice while completing a task in the functional magnetic resonance imaging scanner.
Interventions
TDCS involves passing a weak current through the brain. One variant, cathodal TDCS, can be used to temporarily hyperpolarize cortical pyramidal cells, thereby decreasing neuronal connections. TDCS has been explored as a possible treatment for depression, but results to date are mixed. No work has examined whether TDCS can be used in an individually guided manner to target locations in the parietal cortex and alter the patterns of circuitry dysfunction described previously.
Eligibility Criteria
You may qualify if:
- Between 18-30years old
- Score \> 10 on the QIDS or \> 60 on the PROMIS-A
- We will use a flexible extreme groups recruitment strategy to ensure an adequate distribution of ESC scores. We will ensure that at least 62% of the sample will be composed of those scoring .5 SD above or below the mean, as measured by the NEO-PI-R. This value corresponds to the expected values assuming a normal distribution of the trait.
- Normal or corrected to normal vision with contact lenses
- Able to provide informed consent in English
- Right-handed (Annett criteria)
You may not qualify if:
- Have a history of head trauma with loss of consciousness.
- Have a systemic medical illness that may impact fMRI measures of cerebral blood flow.
- Are pregnant (self report and tested for as part of any scan by the scanning center and not this protocol)
- Not native English speaking or not fluent
- Premorbid NAART IQ estimate\<85;
- Visual disturbance (worse than 20/40 Snellen visual acuity) that is not corrected
- If have visual disturbance, only access to correction with glasses (i.e., no access to contact lenses).
- Left/mixed handedness (Annett criteria), to ensure a uniform hemispheric dominance for interpretation of neuroimaging data
- Active suicidal ideation in need of immediate treatment
- Scoring below the cutoffs on both the QIDS and the PROMIS-A
- History of alcohol/substance use disorder (including nicotine) and/or illicit substance use (except cannabis) over the last 3 months, determined by the MINI. Lifetime/present cannabis use (non-disordered levels) will be allowed, given its common usage in individuals in this age range.
- Current or past psychotic-spectrum disorder
- History of seizures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jay Fournierlead
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
This study was closed due to Covid 19 restrictions. Only 3 people completed the protocol. No conclusions should be drawn from the results reported. Because of the low sample size, no statistical analyses were undertaken.
Results Point of Contact
- Title
- Jay Fournier, PhD
- Organization
- The Ohio State University College of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Jay C Fournier, Ph. D.
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor of Psychiatry
Study Record Dates
First Submitted
October 10, 2020
First Posted
October 22, 2020
Study Start
October 1, 2018
Primary Completion
March 9, 2020
Study Completion
March 9, 2020
Last Updated
January 4, 2022
Results First Posted
January 4, 2022
Record last verified: 2021-12